Coloplast A/S (CLPBY) News Today $9.50 -0.03 (-0.31%) As of 08/13/2025 03:58 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesInsider TradesSEC FilingsShort InterestBuy This Stock CLPBY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Financial Contrast: Coloplast A/S (OTCMKTS:CLPBY) versus Lucid Diagnostics (NASDAQ:LUCD)4 hours ago | americanbankingnews.comColoplast: Despite The Drawdown, Still Not A Buy5 hours ago | seekingalpha.comColoplast A/S - 9M 2024/25 Earnings Release - Invitation to conference call on 19 August 2025 at 11.00am CESTAugust 8, 2025 | finance.yahoo.comCLPBY - Coloplast AS ADR Ownership - MorningstarJuly 16, 2025 | morningstar.comMCLPBY - Coloplast AS ADR Trailing Returns - MorningstarJuly 15, 2025 | morningstar.comMCLPBY - Coloplast AS ADR Valuation - MorningstarJuly 10, 2025 | morningstar.comMSmith Blasts Novo, Coloplast in Danish Life Science RebukeJuly 8, 2025 | msn.comEuropean Stocks Priced Below Estimated Value In June 2025June 26, 2025 | finance.yahoo.comCLPBY Coloplast A/S - Seeking AlphaJune 25, 2025 | seekingalpha.comColoplast: Finally Getting BuyableJune 14, 2025 | seekingalpha.comRBC Capital cuts Coloplast stock rating, lowers price targetMay 10, 2025 | investing.comColoplast A/S (CLPBF) Q2 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comColoplast stock rating cut, target slashed by Deutsche BankMay 6, 2025 | investing.comColoplast A/S CEO Kristian Villumsen steps down as of todayMay 5, 2025 | globenewswire.comColoplast: Cheaper Than In The Past, But Not Yet A BargainMarch 26, 2025 | seekingalpha.comColoplast A/S (CLPBF) Q1 2025 Earnings Call TranscriptFebruary 4, 2025 | seekingalpha.comColoplast A/S - Q1 2024/25 Earnings Release - Invitation to conference call on 4 February 2025 at 11.00am CETJanuary 21, 2025 | globenewswire.comColoplast Still Pricey Even As A High-Quality Med-Tech Growth NameJanuary 9, 2025 | seekingalpha.comColoplast A/S (CLPBF) Q4 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comColoplast A/S (OTCMKTS:CLPBY) Sees Large Drop in Short InterestOctober 29, 2024 | marketbeat.comColoplast A/S - FY 2023/24 Earnings Release - Invitation for conference call on 5 November 2024 at 11.00 CETOctober 21, 2024 | globenewswire.comColoplast A/S (OTCMKTS:CLPBY) Stock Crosses Below 50-Day Moving Average - Here's WhyOctober 17, 2024 | marketbeat.comColoplast A/S (OTCMKTS:CLPBY) Stock Passes Below 50-Day Moving Average of $13.41September 28, 2024 | marketbeat.comColoplast A/S - Financial Calendar 2024-25September 25, 2024 | uk.finance.yahoo.comColoplast A/S - Trading in Coloplast shares by board members, executives or associated personsSeptember 25, 2024 | globenewswire.comColoplast A/S - Trading in Coloplast shares by board members, executives or associated personsSeptember 20, 2024 | globenewswire.comColoplast AS ADR CLPBYSeptember 18, 2024 | morningstar.comMColoplast A/S - Trading in Coloplast shares by board members, executives or associated personsSeptember 3, 2024 | globenewswire.comColoplast A/S - Trading in Coloplast shares by board members, executives or associated personsSeptember 3, 2024 | globenewswire.comColoplast A/S (OTCMKTS:CLPBY) Short Interest UpdateAugust 31, 2024 | marketbeat.comColoplast A-S (B) is about to announce its earnings — here's what Wall Street expectsAugust 19, 2024 | markets.businessinsider.comShort Interest in Coloplast A/S (OTCMKTS:CLPBY) Rises By 55.1%August 15, 2024 | marketbeat.comColoplast A/S (OTCMKTS:CLPBY) Sees Significant Drop in Short InterestJuly 11, 2024 | marketbeat.comColoplast A/S - Invitation to Coloplast's Meet the Management event on 6 June 2024 (gentle reminder)May 16, 2024 | globenewswire.comColoplast expands its Luja™ portfolio with next generation catheter for womenMay 14, 2024 | finance.yahoo.comColoplast A/S (OTCMKTS:CLPBY) Short Interest Up 504.6% in AprilMay 10, 2024 | marketbeat.comColoplast A/S - Trading in Coloplast shares by board members, executives or associated personsMarch 1, 2024 | globenewswire.comColoplast A/S - Trading in Coloplast shares by board members, executives or associated personsFebruary 28, 2024 | globenewswire.comColoplast A/S (CLPBY)February 23, 2024 | finance.yahoo.comColoplast A/S: Coloplast Earnings: Underlying Demand Remains Strong, but Medicare Fraudsters Could Hurt U.S. GrowthFebruary 12, 2024 | finance.yahoo.comColoplast A/S - Allocation of Share OptionsFebruary 9, 2024 | finance.yahoo.comColoplast A/S - Allocation of Share OptionsFebruary 9, 2024 | globenewswire.comColoplast A/S - Interim Financial Report, Q1 2023/24February 9, 2024 | finance.yahoo.comColoplast launches Peristeen® Light for people with bowel disordersFebruary 9, 2024 | finance.yahoo.comColoplast A/S ADRFebruary 7, 2024 | morningstar.comMColoplast launches Biatain® Silicone Fit for pressure injury prevention and wound management in the USJanuary 31, 2024 | finance.yahoo.comColoplast A/S goes ex-dividend tomorrowDecember 7, 2023 | msn.comColoplast A/S - Notice of Annual General Meeting 2023November 14, 2023 | finance.yahoo.comColoplast A/S: Coloplast Earnings: Revenue Growth Remains Solid, but Margin Drag Likely to Last Into 2024November 9, 2023 | finance.yahoo.comColoplast A/S (OTCMKTS:CLPBY) Receives Consensus Rating of "Hold" from AnalystsSeptember 23, 2023 | marketbeat.com Get Coloplast A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPBY and its competitors with MarketBeat's FREE daily newsletter. Email Address CLPBY Media Mentions By Week CLPBY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLPBY News Sentiment▼0.000.71▲Average Medical News Sentiment CLPBY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLPBY Articles This Week▼20▲CLPBY Articles Average Week Get Coloplast A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPBY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Advanced Biomedical Technologies News Fresenius Medical Care AG & Co. KGaA News Micron Solutions News Sartorius News Thermo Fisher Scientific News Intuitive Surgical News IDEXX Laboratories News Edwards Lifesciences News Alcon News IQVIA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CLPBY) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGet This Stock NowThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredAmericans are rushing into gold (but not billionaires!)Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coloplast A/S Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Coloplast A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access